Drug Profile
AR 1
Latest Information Update: 15 Sep 1999
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antiarrhythmics; Ischaemic heart disorder therapies
- Mechanism of Action Calcium channel antagonists; Calmodulin antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Arrhythmias
Most Recent Events
- 15 Sep 1999 No-Development-Reported for Arrhythmias in Armenia (Unknown route)
- 28 Feb 1997 New profile
- 28 Feb 1997 Preclinical development for Arrhythmias in Armenia (Unknown route)